#3 - Clorox (NYSE:CLX)
The Clorox Company (NYSE: CLX) was one of the biggest pandemic winners. CLX stock soared as consumers snapped up their cleaning solutions to keep their homes and businesses as safe as possible. However, 2022 has been a different story. CLX stock is down 17% for the year, which is about on par with the broader market.
It’s all about earnings. The company’s revenue continues to come in above pre-pandemic levels. But earnings are lagging. This suggests that the company may have difficulty passing along its higher costs. However, as inflation pressures are expected to ease in the next five years, analysts expect the company to grow earnings at an 18% pace.
Analysts tracked by MarketBeat advise investors to reduce their position in CLX stock. However, at least five analysts have boosted their price target in the last several months. Plus, with Clorox, you get another dividend aristocrat. The company has increased its dividend for 35 years and currently pays out $4.72 per share.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More - Current Price
- $169.30
- Consensus Rating
- Reduce
- Ratings Breakdown
- 1 Buy Ratings, 9 Hold Ratings, 5 Sell Ratings.
- Consensus Price Target
- $155.00 (8.4% Downside)
